James Mackay, President & CEO, Aristea Therapeutics, serves as an independent board member to two other San Diego-based biopharma companies: Arthrosi Therapeutics and MatriSys Bioscience, and Peabody, MA-based Privo Technologies. What exactly is an independent board member? Mackay keeps it simple: A board member with no (or limited) vested financial interest in the company they’ve been asked to guide.

On June 3, 2021, five biopharma executives and one intellectual property attorney joined Pharmaceutical Executive to discuss collaboration within the industry, a topic that has come front and center since the start of the pandemic. Participants shared their insights on what they feel are some of the most important and pressing collaboration issues in pharma today and […]

As a co-founder, chairman and CEO of Sigyn Therapeutics (pronounced Sig-en) (OTCMarkets:SIGY), a medical device company developing a blood purification system to treat life-threatening inflammatory conditions, including sepsis, Jim Joyce has been down this road before. A 20-year-plus biotech veteran, he was the founder of Aethlon Medical and oversaw the development of its Hemopurifier blood purification technology […]